Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy of oral P5P for chronic treatment of patients with confirmed PNPO deficiency.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

  • Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

NCT number NCT04550572
Study type Interventional
Source Medicure
Contact Pat Follows
Phone 204-594-3410
Status Not yet recruiting
Phase Phase 3
Start date February 2021
Completion date June 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04706013 - Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency Phase 3